# YIF1B

## Overview
YIF1B is a gene that encodes the Yip1 interacting factor homolog B, a membrane trafficking protein involved in intracellular transport processes. This protein is categorized as a transmembrane protein, characterized by its five transmembrane domains, which are crucial for its function in the endoplasmic reticulum (ER) to Golgi transport. YIF1B plays a significant role in the localization and function of the 5-HT1A serotonin receptor, particularly in neuronal cells, by facilitating its transport to distal dendrites. The protein is primarily localized in the ER-Golgi intermediate compartment and the Golgi apparatus, where it may act as a molecular chaperone. Mutations in the YIF1B gene are associated with neurodevelopmental disorders, highlighting its importance in maintaining cellular homeostasis and protein distribution (Carrel2008Targeting; Diaz2020YIF1B).

## Structure
The YIF1B protein is a 311 amino acid protein that is part of a family of five-passed transmembrane proteins. It is predicted to have five transmembrane segments clustered in the C-terminal moiety, which are crucial for its function in membrane trafficking (Carrel2008Targeting). The protein features a long hydrophilic N-terminal domain located within the cytoplasm and a very short C terminus oriented towards the endoplasmic reticulum (ER) lumen (Carrel2008Targeting). This structural arrangement is consistent with its role in ER-to-Golgi trafficking, as it shares homology with the yeast protein Yif1p, known for similar functions (Carrel2008Targeting).

YIF1B is well conserved across species, with high identity scores compared to other organisms, such as 97% with Mus musculus and 89% with Homo sapiens, indicating a conserved structural and functional role (Carrel2008Targeting). The protein's topology in the Golgi membrane includes the five transmembrane domains and a large cytoplasmic N terminus, which are essential for its interaction with other proteins, such as the 5-HT1A serotonin receptor (Carrel2008Targeting). The presence of missense variants in or near these transmembrane domains can impact YIF1B function, as observed in certain neurodevelopmental disorders (Medico2021Expanding).

## Function
YIF1B is a membrane trafficking protein involved in the regulation of vesicular transport within cells, particularly in the endoplasmic reticulum (ER) to Golgi transport. It plays a crucial role in the proper localization and function of the 5-HT1A serotonin receptor in neurons. YIF1B interacts with the C-terminal segment of the 5-HT1A receptor, facilitating its transport to distal dendrites, which is essential for serotonin signaling pathways in the brain (Carrel2008Targeting). This interaction is specific, as YIF1B does not affect the localization of other receptors, such as the somatostatin sst2A receptor or the serotonin 5-HT3A receptor (Carrel2008Targeting).

YIF1B is primarily localized in the ER-Golgi intermediate compartment (ERGIC) and the Golgi apparatus, where it may function as a molecular chaperone, aiding in the proper conformation or assembly of proteins for correct delivery (Shaik2019Characteristics). It is also involved in the lysosomal targeting of the ABC transporter TAPL, although it is not essential for this process, indicating potential redundancy in trafficking pathways (Graab2019Lysosomal). YIF1B's role in these processes highlights its importance in maintaining cellular homeostasis and protein distribution.

## Clinical Significance
Mutations in the YIF1B gene are associated with a neurodevelopmental disorder known as Kaya-Barakat-Masson syndrome. This condition is characterized by severe neurological symptoms, including progressive encephalopathy, movement disorders, microcephaly, epilepsy, and developmental delays. Structural brain abnormalities such as cortical atrophy and a thin corpus callosum are also observed in affected individuals (Medico2021Expanding). 

YIF1B mutations lead to a post-natal neurodevelopmental syndrome with symptoms like severe cognitive impairment, motor alterations, seizures, and swallowing difficulties. MRI findings in patients often reveal brain structure abnormalities, including delayed myelination, thin corpus callosum, cerebellar vermian and pons atrophies, and ventricular dilatation (Diaz2020YIF1B). 

The gene is crucial for the integrity of the Golgi apparatus and primary cilia, and its mutations result in significant neurodevelopmental alterations. These include cerebellar atrophy and visual impairments, such as nystagmus and optic atrophy, which are mirrored in Yif1b knockout mice (Diaz2020YIF1B). 

YIF1B mutations are also linked to Golgipathies, a class of diseases involving Golgi apparatus proteins, affecting ER-Golgi apparatus transport essential for neuronal function and myelination (Diaz2020YIF1B).

## Interactions
YIF1B is known to interact with several proteins, playing a crucial role in intracellular trafficking. It specifically interacts with the 5-HT1A serotonin receptor (5-HT1A R), facilitating its localization to neuronal dendrites. This interaction is mediated through the C-terminal domain of the 5-HT1A R and has been confirmed by yeast two-hybrid screening and GST pull-down assays (Carrel2008Targeting). YIF1B is also involved in a protein complex with Rab6, α2/β2 tubulin, Yipf5, and molecular motors such as Kif5B and dynein, which are essential for the transport of 5-HT1A Rs along microtubules (Angelotti2022Exploring).

YIF1B interacts with Yipf family members, particularly Yipf5, which influences its Golgi localization (Angelotti2022Exploring). It also forms a scaffolding complex with Rab6 and Yipf5, directing the location of cargo proteins (Angelotti2022Exploring). Additionally, YIF1B has been identified as a high-confidence interacting protein with the ABC transporter TAPL, although it is not essential for TAPL targeting (Graab2019Lysosomal). These interactions highlight YIF1B's role in the trafficking and localization of proteins within cells, particularly in the context of neuronal function.


## References


[1. (Medico2021Expanding) Eva Medico Salsench, Reza Maroofian, Ruizhi Deng, Kristina Lanko, Anita Nikoncuk, Belén Pérez, Obdulia Sánchez-Lijarcio, Salvador Ibáñez-Mico, Antonina Wojcik, Marcelo Vargas, Nouriya Abbas Al-Sannaa, Marian Y Girgis, Tainá Regina Damaceno Silveira, Peter Bauer, Audrey Schroeder, Chin-To Fong, Amber Begtrup, Meisam Babaei, Mehran Beiraghi Toosi, Farah Ashrafzadeh, Shima Imannezhad, Mohammad Doosti, Najmeh Ahangari, Paria Najarzadeh Torbati, Ehsan Ghayoor Karimiani, David Murphy, Elisa Cali, Ibrahim H Kaya, Mohammad AlMuhaizea, Dilek Colak, Kelly J Cardona-Londoño, Stefan T Arold, Henry Houlden, Aida Bertoli-Avella, Namik Kaya, and Tahsin Stefan Barakat. Expanding the mutational landscape and clinical phenotype of the yif1b related brain disorder. Brain, 144(10):e85–e85, August 2021. URL: http://dx.doi.org/10.1093/brain/awab297, doi:10.1093/brain/awab297. This article has 2 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awab297)

[2. (Shaik2019Characteristics) Shaheena Shaik, Himani Pandey, Satish Kumar Thirumalasetti, and Nobuhiro Nakamura. Characteristics and functions of the yip1 domain family (yipf), multi-span transmembrane proteins mainly localized to the golgi apparatus. Frontiers in Cell and Developmental Biology, July 2019. URL: http://dx.doi.org/10.3389/fcell.2019.00130, doi:10.3389/fcell.2019.00130. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2019.00130)

[3. (Graab2019Lysosomal) Philipp Graab, Christoph Bock, Konstantin Weiss, Alexander Hirth, Nicole Koller, Markus Braner, Jennifer Jung, Frank Loehr, Robert Tampé, Christian Behrends, and Rupert Abele. Lysosomal targeting of the abc transporter tapl is determined by membrane-localized charged residues. Journal of Biological Chemistry, 294(18):7308–7323, May 2019. URL: http://dx.doi.org/10.1074/jbc.ra118.007071, doi:10.1074/jbc.ra118.007071. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra118.007071)

[4. (Angelotti2022Exploring) Timothy Angelotti. Exploring the eukaryotic yip and reep/yop superfamily of membrane-shaping adapter proteins (msaps): a cacophony or harmony of structure and function? Frontiers in Molecular Biosciences, August 2022. URL: http://dx.doi.org/10.3389/fmolb.2022.912848, doi:10.3389/fmolb.2022.912848. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2022.912848)

[5. (Carrel2008Targeting) Damien Carrel, Justine Masson, Sana Al Awabdh, Catherine Borg Capra, Zsolt Lenkei, Michel Hamon, Michel Boris Emerit, and Michèle Darmon. Targeting of the 5-ht1aserotonin receptor to neuronal dendrites is mediated by yif1b. The Journal of Neuroscience, 28(32):8063–8073, August 2008. URL: http://dx.doi.org/10.1523/JNEUROSCI.4487-07.2008, doi:10.1523/jneurosci.4487-07.2008. This article has 73 citations.](https://doi.org/10.1523/JNEUROSCI.4487-07.2008)

[6. (Diaz2020YIF1B) Jorge Diaz, Xavier Gérard, Michel-Boris Emerit, Julie Areias, David Geny, Julie Dégardin, Manuel Simonutti, Marie-Justine Guerquin, Thibault Collin, Cécile Viollet, Jean-Marie Billard, Christine Métin, Laurence Hubert, Farzaneh Larti, Kimia Kahrizi, Rebekah Jobling, Emanuele Agolini, Ranad Shaheen, Alban Zigler, Virginie Rouiller-Fabre, Jean-Michel Rozet, Serge Picaud, Antonio Novelli, Seham Alameer, Hossein Najmabadi, Ronald Cohn, Arnold Munnich, Magalie Barth, Licia Lugli, Fowzan S Alkuraya, Susan Blaser, Maha Gashlan, Claude Besmond, Michèle Darmon, and Justine Masson. Yif1b mutations cause a post-natal neurodevelopmental syndrome associated with golgi and primary cilium alterations. Brain, 143(10):2911–2928, October 2020. URL: http://dx.doi.org/10.1093/brain/awaa235, doi:10.1093/brain/awaa235. This article has 13 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awaa235)